Nom du produit:4-Boc-7-Bocamino-3,4-dihydroquinoxalin-2-one
IUPAC Name:tert-butyl 6-{[(tert-butoxy)carbonyl]amino}-3-oxo-1,2,3,4-tetrahydroquinoxaline-1-carboxylate
- CAS:959246-52-7
- Formule moléculaire:C18H25N3O5
- Pureté:97%
- Numéro de catalogue:CM141873
- Poids moléculaire:363.41
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:959246-52-7
- Formule moléculaire:C18H25N3O5
- Point de fusion:-
- Code SMILES:O=C1NC2=C(C=CC(NC(OC(C)(C)C)=O)=C2)N(C(OC(C)(C)C)=O)C1
- Densité:
- Numéro de catalogue:CM141873
- Poids moléculaire:363.41
- Point d'ébullition:476.9°C at 760 mmHg
- N° Mdl:
- Stockage:Store at 2-8°C.
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.